STAG3: A Potential Drug Target Or Biomarker (G10734)

Target Name: STAG3

NCBI ID: G10734

STAG3

STAG3: A Potential Drug Target Or Biomarker

STAG3, also known as Stromal Antigen 3, is a protein that is expressed in various tissues throughout the body, including the skin, hair, nails, and connective tissue. It is a member of the STAG family, which includes STAG1, STAG2, and STAG3, and is involved in the regulation of cell growth, differentiation, and survival.

Recent studies have suggested that STAG3 may have potential as a drug target or biomarker. Several factors support this potential. First, STAG3 has been shown to play a role in the development and progression of various diseases, including cancer. For example, STAG3 has been shown to be overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, STAG3 has been shown to be involved in the regulation of cell survival and proliferation, which could make it a useful target for drugs that are designed to inhibit cell proliferation or survival.

Second, STAG3 has been shown to be involved in a variety of cellular processes that are important for human health, including wound healing and tissue regeneration. This suggests that it may be a useful target for drugs that are designed to stimulate wound healing and tissue regeneration.

Third, STAG3 has been shown to be involved in the regulation of cell adhesion and migration. This suggests that it may be a useful target for drugs that are designed to inhibit cell adhesion or migration, which could be useful for a variety of diseases, including cancer.

Finally, STAG3 has been shown to be involved in the regulation of cell signaling pathways, which could make it a useful target for drugs that are designed to inhibit signaling pathways that are involved in a variety of diseases, including cancer.

In conclusion, STAG3 is a protein that has been shown to play a role in the regulation of various cellular processes that are important for human health. As a result, it may be a useful target for drugs that are designed to inhibit its activity or enhance its activity. Further research is needed to fully understand the potential of STAG3 as a drug target or biomarker.

Protein Name: Stromal Antigen 3

Functions: Meiosis specific component of cohesin complex. The cohesin complex is required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The meiosis-specific cohesin complex probably replaces mitosis specific cohesin complex when it dissociates from chromatin during prophase I

The "STAG3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STAG3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets